FARBERG, A.; SIEGEL, J. .; KURLEY, S.; FITZGERALD, A.; PRASAI, A.; GOLDBERG, M.; IBRAHIM, S.; ESTRADA, S. Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s164, 2023. DOI: 10.25251/skin.7.supp.164. Disponível em: https://jofskin.org/index.php/skin/article/view/2019. Acesso em: 3 jul. 2024.